Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD

PHASE2RecruitingINTERVENTIONAL

Enrollment

222

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

February 18, 2025

Study Completion Date

February 18, 2025

Conditions

Chronic Kidney Diseases

Interventions

DRUG

Dapagliflozin 10 mg

The intervention arm consists of dapagliflozin 10 mg orally once daily

DRUG

Placebo

The comparator arm consists of placebo orally once daily

Trial Locations (1)

RECRUITING

Gentofte Hospital, Copenhagen

All Listed Sponsors

lead

Tor Biering-Sørensen

OTHER